Physician profile
Timothy E Truman
NPI 1952834897
$1,019.38
in general payments reported to CMS, 2019-2025
15 companies · $431 in 2025
The $431 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $100 · 2022: $171 · 2023: $88.59 · 2024: $109 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $226.40 | 2024-2025 | Airsupra, Breztri, Andexxa |
| Allergan, INC. | $220.05 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $158.87 | 2022-2023 | Xarelto |
| Abbvie INC. | $98.59 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $50.75 | 2024-2025 | Rotateq, Vaxneuvance, Vaxelis |
| Lilly USA, LLC | $47.33 | 2024-2025 | Zepbound, Kisunla, Jardiance |
| Exact Sciences Corporation | $42.40 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Seqirus USA INC | $38.78 | 2024-2025 | Flucelvax, Fluad |
| Vanda Pharmaceuticals INC. | $21.76 | 2025 | Fanapt |
| Pfizer INC. | $21.61 | 2025 | |
| Stryker Corporation | $20.13 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.86 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $18.69 | 2025 | |
| Astellas Pharma US INC | $17.81 | 2024 | Veozah |
| Kowa Pharmaceuticals America, INC. | $16.35 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Truman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.